• Info
  • Insider Ownership

Insider Trading & Ownership of SV7 Impact Medicine Fund LP

Location
London, United Kingdom
Summary
The estimated value of insider holdings of SV7 Impact Medicine Fund LP is at least $2,678,630 dollars as of 03 Nov 2021. SV7 Impact Medicine Fund LP is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $2.68M.
Signature
/s/ Kathleen R. Henry, pursuant to Power of Attorney for SV7 Impact Medicine Fund LP
All Insider Reports
All Insider Reports

Notify me when SV7 Impact Medicine Fund LP files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of SV7 Impact Medicine Fund LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
XLO Xilio Therapeutics, Inc. 10%+ Owner $2,678,630 26 Oct 2021

Insider Transactions Reported by SV7 Impact Medicine Fund LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.